The Future of Myeloma Treatment: What’s Next?
Topics Covered
We invite you to learn more about:
- Current myeloma treatments
- What the future holds for myeloma treatment
- Side-effect management
Program Materials
Speaker
C. Ola Landgren, MD, PhD
Professor of Medicine
Chief, Division of Myeloma, Department of Medicine
Director, Sylvester Myeloma Institute
Co-Leader, Translational and Clinical Oncology Program
Paul J. DiMare Endowed Chair in Immunotherapy
Sylvester Comprehensive Cancer Center
University of Miami
Miami, FL
Program Support
Support for this program provided by AbbVie Inc.; Genentech, a member of the Roche Group; GSK plc; Johnson & Johnson; and Sanofi.
patient-education-webcasts/living-multiple-myeloma
Topics Covered
We invite you to learn more about:
- New and emerging therapies for myeloma
- What to do when myeloma relapses
- CAR T-cell therapy for myeloma
- The importance of discussing quality-of-life issues with your treatment team
Speaker
Noa Biran, MD
Assistant Professor of Medicine
John Theurer Cancer Center
Multiple Myeloma Division
Hackensack Meridian Health
Hackensack, NJ
Program Materials
Program Support
Support for this program is provided by Bristol Myers Squibb; Genentech & Biogen; GlaxoSmithKline; Janssen Oncology; and Oncopeptides.